Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Takeuchi

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Oncology|September 14, 2023
Neoadjuvant Triplet Chemotherapy with Docetaxel, Cisplatin plus 5-Fluorouracil versus Docetaxel, Cisplatin plus S-1 for Advanced Esophageal Squamous cell Carcinoma: Propensity Score Matched AnalysisJunya Kitadani, Toshiyasu Ojima, Keiji Hayata, et al.
Langenbeck'S Archives of Surgery|November 29, 2023
Impact of zero anastomotic leakage after esophagectomy followed by whole stomach reconstruction for esophageal cancer: prospective cohort studyJunya Kitadani, Toshiyasu Ojima, Keiji Hayata, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 11, 2022
Venous Invasion Is a Risk Factor for Recurrence of pT1 Gastric Cancer with Lymph Node MetastasisAkihiro Takeuchi, Toshiyasu Ojima, Masahiro Katsuda, et al.
Annals of Gastroenterological Surgery|January 5, 2026
Prolonged Prophylactic Antibiotics Based on Preoperative Bile Culture Reduce Surgical Site Infections After Pancreaticoduodenectomy Following Preoperative Biliary Drainage: A Propensity-Matched AnalysisKyohei Matsumoto, Atsushi Shimizu, Yuji Kitahata, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 22, 2022
Risk Factors for Chronic Atrial Fibrillation Development After Esophagectomy for Esophageal CancerManabu Kashiwagi, Toshiyasu Ojima, Keiji Hayata, et al.
Anticancer Research|September 9, 2018
Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal CancerKeiji Hayata, Toshiyasu Ojima, Mikihito Nakamori, et al.
Scientific Reports|March 1, 2022
Tumor RNA transfected DCs derived from iPS cells elicit cytotoxicity against cancer cells induced from colorectal cancer patients in vitroShimpei Maruoka, Toshiyasu Ojima, Hiromitsu Iwamoto, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 8, 2024
Long-Term Outcomes of the Treatment for Gastric Tube Cancer After Esophagectomy for Esophageal CancerJunya Kitadani, Keiji Hayata, Taro Goda, et al.
Surgical Endoscopy|February 19, 2022
Laparoscopic sleeve gastrectomy for morbid obesity improves gut microbiota balance, increases colonic mucosal-associated invariant T cells and decreases circulating regulatory T cellsNaoki Fukuda, Toshiyasu Ojima, Keiji Hayata, et al.
Surgical Oncology|June 10, 2025
Octogenarians with lower BMI have comparatively poor survival in potentially resectable pancreatic cancer: outcomes over 5-year follow-upHideki Motobayashi, Atsushi Shimizu, Yuji Kitahata, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Oncology|September 14, 2023
Neoadjuvant Triplet Chemotherapy with Docetaxel, Cisplatin plus 5-Fluorouracil versus Docetaxel, Cisplatin plus S-1 for Advanced Esophageal Squamous cell Carcinoma: Propensity Score Matched AnalysisJunya Kitadani, Toshiyasu Ojima, Keiji Hayata, et al.
Langenbeck'S Archives of Surgery|November 29, 2023
Impact of zero anastomotic leakage after esophagectomy followed by whole stomach reconstruction for esophageal cancer: prospective cohort studyJunya Kitadani, Toshiyasu Ojima, Keiji Hayata, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 11, 2022
Venous Invasion Is a Risk Factor for Recurrence of pT1 Gastric Cancer with Lymph Node MetastasisAkihiro Takeuchi, Toshiyasu Ojima, Masahiro Katsuda, et al.
Annals of Gastroenterological Surgery|January 5, 2026
Prolonged Prophylactic Antibiotics Based on Preoperative Bile Culture Reduce Surgical Site Infections After Pancreaticoduodenectomy Following Preoperative Biliary Drainage: A Propensity-Matched AnalysisKyohei Matsumoto, Atsushi Shimizu, Yuji Kitahata, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 22, 2022
Risk Factors for Chronic Atrial Fibrillation Development After Esophagectomy for Esophageal CancerManabu Kashiwagi, Toshiyasu Ojima, Keiji Hayata, et al.
Anticancer Research|September 9, 2018
Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal CancerKeiji Hayata, Toshiyasu Ojima, Mikihito Nakamori, et al.
Scientific Reports|March 1, 2022
Tumor RNA transfected DCs derived from iPS cells elicit cytotoxicity against cancer cells induced from colorectal cancer patients in vitroShimpei Maruoka, Toshiyasu Ojima, Hiromitsu Iwamoto, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 8, 2024
Long-Term Outcomes of the Treatment for Gastric Tube Cancer After Esophagectomy for Esophageal CancerJunya Kitadani, Keiji Hayata, Taro Goda, et al.
Surgical Endoscopy|February 19, 2022
Laparoscopic sleeve gastrectomy for morbid obesity improves gut microbiota balance, increases colonic mucosal-associated invariant T cells and decreases circulating regulatory T cellsNaoki Fukuda, Toshiyasu Ojima, Keiji Hayata, et al.
Surgical Oncology|June 10, 2025
Octogenarians with lower BMI have comparatively poor survival in potentially resectable pancreatic cancer: outcomes over 5-year follow-upHideki Motobayashi, Atsushi Shimizu, Yuji Kitahata, et al.
Pageof 7